Filing Details
- Accession Number:
- 0001140361-13-031230
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-08 18:36:08
- Reporting Period:
- 2013-08-07
- Filing Date:
- 2013-08-08
- Accepted Time:
- 2013-08-08 18:36:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
890846 | Uroplasty Inc | UPI | Surgical & Medical Instruments & Apparatus (3841) | 411719250 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1417173 | Robert Kill | Uroplasty, Inc. 5420 Feltl Road Minnetonka MN 55343 | President, Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-08-06 | 6,050 | $2.77 | 316,050 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2013-08-07 | 30,000 | $2.78 | 346,050 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | non-qualified stock options | $5.26 | 2011-12-06 | 2017-12-05 | 4,900 | 4,900 | Direct |
Common Stock | non-qualified stock options | $4.83 | 2012-09-14 | 2018-09-13 | 5,475 | 5,475 | Direct |
Common Stock | non-qualified stock options | $3.76 | 2013-09-13 | 2019-09-12 | 7,025 | 7,025 | Direct |
Common Stock | non-qualified stock options | $2.34 | 2014-07-23 | 2020-07-22 | 700,000 | 700,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2017-12-05 | 4,900 | 4,900 | Direct |
2018-09-13 | 5,475 | 5,475 | Direct |
2019-09-12 | 7,025 | 7,025 | Direct |
2020-07-22 | 700,000 | 700,000 | Direct |
Footnotes
- Becomes exercisable with respect to one-third of the shares on the first, second and third anniversaries of the grant date (the grant date being one year prior to such date).
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.75 to $2.80 per share, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.66 to $2.85 per share, inclusive.